{"id":"W2019445754","doi":"10.1016/j.pupt.2011.07.006","title":"24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD","year":2011,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Bronchodilation; Medicine; Pharmacokinetics; Indacaterol; Tolerability; Bronchodilator; Anesthesia; Placebo; COPD; Spirometry; Crossover study; Inhaler; Pharmacology; Adverse effect; Internal medicine; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006894775,0.0006872421,0.002429088,0.0004616642,0.0004296168,0.0005307447,0.0003649375,0.001445961,0.001168065],"category_scores_gemma":[0.001646003,0.000257955,0.0006174757,0.0003486207,0.0003637423,0.0004336727,0.0003214093,0.001643964,0.0003183629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004770826,"about_ca_system_score_gemma":0.0004582533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001703137,"about_ca_topic_score_gemma":0.00318801,"domain_scores_codex":[0.9996045,0.0001352045,0.00004384805,0.00004851306,0.0000861984,0.00008175372],"domain_scores_gemma":[0.998926,0.0003342157,0.0001774119,0.00006680898,0.00008752661,0.0004079749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.432645,0.006769794,0.2049559,0.001197256,0.002094965,0.01077748,0.001258542,0.001680724,0.1796023,0.000233859,0.003797767,0.1549863],"study_design_scores_gemma":[0.002996189,0.04167644,0.929134,0.00009521005,0.0009201575,0.00302654,0.0004040645,0.002036363,0.01679365,0.0001240291,0.002695268,0.0000981902],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927133,0.00538708,0.0002279231,0.000309207,0.0001753665,0.00007013685,0.0002661167,0.00004571166,0.0008051059],"genre_scores_gemma":[0.9976918,0.001247332,0.0001259433,0.0001338447,0.0002010378,0.0000362065,0.0001778774,0.000006128826,0.0003799346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002429088,"threshold_uncertainty_score":0.003907561,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07730351345816831,"score_gpt":0.3302268691855251,"score_spread":0.2529233557273568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}